Hugosson J - Search Results

1

Outcomes of men with screen-detected prostate cancer eligible for active surveillance who were managed expectantly.

van den Bergh RC, Roemeling S, Roobol MJ, Aus G, Hugosson J, Rannikko AS, Tammela TL, Bangma CH, Schröder FH. van den Bergh RC, et al. Among authors: hugosson j. Eur Urol. 2009 Jan;55(1):1-8. doi: 10.1016/j.eururo.2008.09.007. Epub 2008 Sep 17. Eur Urol. 2009. PMID: 18805628

2

[Transrectal ultrasonography of the prostate--prolonged finger of the urologist].

Aus G, Hugosson J. Aus G, et al. Among authors: hugosson j. Lakartidningen. 1992 Nov 4;89(45):3827-31. Lakartidningen. 1992. PMID: 1281251 Review. Swedish. No abstract available.

3

Impact of competing mortality on the cancer-related mortality in localized prostate cancer.

Aus G, Pileblad E, Hugosson J. Aus G, et al. Among authors: hugosson j. Urology. 1995 Nov;46(5):672-5. doi: 10.1016/S0090-4295(99)80299-4. Urology. 1995. PMID: 7495119

4

Prostate cancer mortality in patients surviving more than 10 years after diagnosis.

Hugosson J, Aus G, Bergdahl C, Bergdahl S. Hugosson J, et al. J Urol. 1995 Dec;154(6):2115-7. J Urol. 1995. PMID: 7500471

5

Volume determinations of the whole prostate and of adenomas by transrectal ultrasound in patients with clinically benign prostatic hyperplasia: correlation of resected weight, blood loss and duration of operation.

Aus G, Bergdahl S, Hugosson J, Norlén L. Aus G, et al. Among authors: hugosson j. Br J Urol. 1994 Jun;73(6):659-63. doi: 10.1111/j.1464-410x.1994.tb07552.x. Br J Urol. 1994. PMID: 7518318

6

Effects of 3 months' neoadjuvant hormonal treatment with a GnRH analogue (triptorelin) prior to radical retropubic prostatectomy on prostate-specific antigen and tumour volume in prostate cancer.

Aus G, Brändstedt S, Häggman M, Pedersen K, de la Torre M, Hugosson J. Aus G, et al. Among authors: hugosson j. Eur Urol. 1994;26(1):22-8. doi: 10.1159/000475337. Eur Urol. 1994. PMID: 7523130 Clinical Trial.

7

Influence of benign prostatic hyperplasia, testosterone and age on serum levels of prostate specific antigen.

Aus G, Bergdahl S, Hugosson J, Lodding P, Norlén L. Aus G, et al. Among authors: hugosson j. Scand J Urol Nephrol. 1994 Dec;28(4):379-84. doi: 10.3109/00365599409180517. Scand J Urol Nephrol. 1994. PMID: 7533925

8

Long-term survival and mortality in prostate cancer treated with noncurative intent.

Aus G, Hugosson J, Norlén L. Aus G, et al. Among authors: hugosson j. J Urol. 1995 Aug;154(2 Pt 1):460-5. doi: 10.1097/00005392-199508000-00033. J Urol. 1995. PMID: 7541864 Review.

9

Need for hospital care and palliative treatment for prostate cancer treated with noncurative intent.

Aus G, Hugosson J, Norlén L. Aus G, et al. Among authors: hugosson j. J Urol. 1995 Aug;154(2 Pt 1):466-9. doi: 10.1097/00005392-199508000-00034. J Urol. 1995. PMID: 7541865

10

Transrectal ultrasound examination of the prostate: complications and acceptance by patients.

Aus G, Hermansson CG, Hugosson J, Pedersen KV. Aus G, et al. Among authors: hugosson j. Br J Urol. 1993 Apr;71(4):457-9. doi: 10.1111/j.1464-410x.1993.tb15992.x. Br J Urol. 1993. PMID: 8499990

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

285 results

Search Page

Filters